Mobile App

WHERE THE BRIGHTEST MINDS in health and IT meet.

Enabling Precision Medicine Through NGS-based Screening and Diagnostic Testing

February 20, 2017 — 11:15AM EST - 12:15PM EST


Join Intel for a HIMSS17 Lunch & Learn

 Presented by:

Ramon Felciano, CTO and Vice President, Technology and Global Strategy

Global Manager, Clinical Testing Solutions, QIAGEN Bioinformatics


Kristina Kermanshahche, Global Director of Life Sciences, Intel

Are you interested in NGS-based genetic testing across a range of cancer, hereditary, and rare diseases?

Learn how a leading academic hospital used a robust informatics platform to accelerate the deployment of validated precision medicine capabilities from sample to insight.

QIAGEN provides an instrument-, platform-, assay- and pipeline-agnostic solution, that enables health care providers to scale sequencing, analysis, interpretation and reporting of screening, diagnostic and monitoring test offerings, fully integrated with hospital information systems.

Join the discussion on the importance of cost-effective and automated approaches for scaling an organizational capacity for analysis, classification and clinical reporting of relevant variants for delivery to physician providers.

Lunch and refreshments will be served.


in health and IT meet.